Abraham Morgentaler, MD, examines a study reported by Vigen et al in The Journal of the American Medical Association, that assessed rates of death, myocardial infaction (MI), and stroke in men who received testosterone therapy for hypogonadism, and discusses the results of this study in the context of the existing literature about testosterone and cardiovascular risk.
This educational activity is eligible for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ through January 10, 2015.
Doctor Is In—Case 8
Joseph, a 45-year-old male who has end-stage nonischemic dilated cardiomyopathy and has a left ventricular assist device in place, has been referred to a urologist because of his complaint of difficulty with sexual function and activities. This educational activity is eligible for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ through April 30, 2015.